These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38726149)

  • 1. Tumor suppressor function of RBMS3 overexpression in EOC associated with immune cell infiltration.
    Yin T; Zhang Y; Zhao Y; Zhang X; Han S; Wang Y; Yang B
    Heliyon; 2024 May; 10(9):e30603. PubMed ID: 38726149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIPE2 acts as a tumor suppressor and correlates with tumor microenvironment immunity in epithelial ovarian cancer.
    Xu S; Gao X; Qiu J; Hong F; Gao F; Wang X; Zhang S
    Aging (Albany NY); 2023 Feb; 15(4):1052-1073. PubMed ID: 36801818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling.
    Wu G; Cao L; Zhu J; Tan Z; Tang M; Li Z; Hu Y; Yu R; Zhang S; Song L; Li J
    Clin Cancer Res; 2019 Feb; 25(3):1022-1035. PubMed ID: 30279231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblasts-derived FMO2 as a biomarker of macrophage infiltration and prognosis in epithelial ovarian cancer.
    Yu S; Yang R; Xu T; Li X; Wu S; Zhang J
    Gynecol Oncol; 2022 Nov; 167(2):342-353. PubMed ID: 36114029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
    Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
    Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of RBMS3 predicts a favorable prognosis in human gallbladder carcinoma.
    Wu Y; Meng D; You Y; Sun R; Yan Q; Bao J; Sun Y; Yun D; Li Y; Sun D
    Oncol Rep; 2020 Jul; 44(1):55-68. PubMed ID: 32627033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer.
    Chen Y; Zhang L; Lv R; Zhang WQ
    Asian Pac J Cancer Prev; 2013; 14(10):5883-90. PubMed ID: 24289594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive bioinformatics analysis confirms RBMS3 as the central candidate biological target for ovarian cancer.
    Wang M; Fu X; Wang W; Zhang Y; Jiang Z; Gu Y; Chu M; Shao Y; Li S
    Med Eng Phys; 2022 Dec; 110():103883. PubMed ID: 36075788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer.
    Wouters M; Dijkgraaf EM; Kuijjer ML; Jordanova ES; Hollema H; Welters M; van der Hoeven J; Daemen T; Kroep JR; Nijman HW; van der Burg SH
    Oncoimmunology; 2014 Dec; 3(12):e962397. PubMed ID: 25964862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
    Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
    Front Immunol; 2022; 13():956224. PubMed ID: 36032075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of RBMS3 in Breast Cancer Progression.
    Górnicki T; Lambrinow J; Mrozowska M; Romanowicz H; Smolarz B; Piotrowska A; Gomułkiewicz A; Podhorska-Okołów M; Dzięgiel P; Grzegrzółka J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma.
    Liang YN; Liu Y; Meng Q; Li X; Wang F; Yao G; Wang L; Fu S; Tong D
    Med Oncol; 2015 Feb; 32(2):459. PubMed ID: 25588924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of RBMS3 and SFRP1 are associated with poor prognosis in patients with gastric cancer.
    Zhang T; Wu Y; Fang Z; Yan Q; Zhang S; Sun R; Khaliq J; Li Y
    Am J Cancer Res; 2016; 6(11):2679-2689. PubMed ID: 27904780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression.
    Zhu L; Xi PW; Li XX; Sun X; Zhou WB; Xia TS; Shi L; Hu Y; Ding Q; Wei JF
    J Exp Clin Cancer Res; 2019 Feb; 38(1):105. PubMed ID: 30819235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicle-Packaged circATP2B4 Mediates M2 Macrophage Polarization via miR-532-3p/SREBF1 Axis to Promote Epithelial Ovarian Cancer Metastasis.
    Wang F; Niu Y; Chen K; Yuan X; Qin Y; Zheng F; Cui Z; Lu W; Wu Y; Xia D
    Cancer Immunol Res; 2023 Feb; 11(2):199-216. PubMed ID: 36512324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.
    Khan AN; Kolomeyevskaya N; Singel KL; Grimm MJ; Moysich KB; Daudi S; Grzankowski KS; Lele S; Ylagan L; Webster GA; Abrams SI; Odunsi K; Segal BH
    Oncotarget; 2015 May; 6(13):11310-26. PubMed ID: 25888637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of RNA-binding protein RBMS3 as a potential biomarker for immunotherapy in bladder cancer.
    Praygod TF; Li J; Li H; Tan W; Hu Z; Zhou L
    Cancer Biomark; 2024 Aug; ():. PubMed ID: 39392600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTTG1IP (PBF) is a prognostic marker and correlates with immune infiltrate in ovarian cancer.
    Ma R; Tang Z; Wang J
    Am J Transl Res; 2023; 15(1):27-46. PubMed ID: 36777854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH; Liu Y; Li JL
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
    Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.